Comparison Of Health Care Costs Between Rheumatoid Arthritis Patients Initiating First Or Second-Line Subcutaneous Abatacept, Adalimumab, Or Etancercept- A Difference-In-Difference Analysis
May 1, 2014, 00:00
10.1016/j.jval.2014.03.263
https://www.valueinhealthjournal.com/article/S1098-3015(14)00314-3/fulltext
Title :
Comparison Of Health Care Costs Between Rheumatoid Arthritis Patients Initiating First Or Second-Line Subcutaneous Abatacept, Adalimumab, Or Etancercept- A Difference-In-Difference Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00314-3&doi=10.1016/j.jval.2014.03.263
First page :
A44
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
1299